Those receiving COVAXIN have been asked to sign a consent form.
India began its COVID-19 vaccination drive on Saturday with two approved vaccinations Serum Institute of India’s Covishield — developed by Oxford-AstraZeneca and Bharat Biotech’s COVAXIN. Those receiving Bharat Biotech’s COVAXIN have been asked to sign a consent form before being vaccinated as the vaccine “has been allowed by the government in clinical trial mode”.
The screening and consent form adds that compensation for serious adverse events will be paid by the company if it is proven to be causally related to the vaccine.
Also read: Coronavirus | Indian scientists divided over nod for Covaxin
“The clinical efficacy of COVAXIN is yet to be established and it is still being studied in phase 3 clinical trials. Hence, it is important to appreciate that receiving the vaccine does not mean that other precautions related to Covid-19 need not be followed. The Central Licensing Authority has granted…
